Does BELUMOSUDIL Cause Product dose omission issue? 143 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Product dose omission issue have been filed in association with BELUMOSUDIL (Rezurock). This represents 5.5% of all adverse event reports for BELUMOSUDIL.
143
Reports of Product dose omission issue with BELUMOSUDIL
5.5%
of all BELUMOSUDIL reports
1
Deaths
32
Hospitalizations
How Dangerous Is Product dose omission issue From BELUMOSUDIL?
Of the 143 reports, 1 (0.7%) resulted in death, 32 (22.4%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELUMOSUDIL. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does BELUMOSUDIL Cause?
Inappropriate schedule of product administration (377)
Product use in unapproved indication (340)
Fatigue (246)
Nausea (154)
Drug ineffective (141)
Diarrhoea (136)
Death (135)
Condition aggravated (127)
Off label use (124)
Dyspnoea (114)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which BELUMOSUDIL Alternatives Have Lower Product dose omission issue Risk?
BELUMOSUDIL vs BELVIQ
BELUMOSUDIL vs BELZUTIFAN
BELUMOSUDIL vs BEMPEDOIC ACID
BELUMOSUDIL vs BEMPEDOIC ACID\EZETIMIBE
BELUMOSUDIL vs BEMPEGALDESLEUKIN